Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2142-2013Class II

LeGoo Endovascular Occlusion Gel-0.5 mL LeGoo w/ no Cannula Product Number: PV-50 LeGoo is a water-soluble...

Genzyme Corporation, A Sanofi Company / initiated 2013-06-21 / Terminated / root cause: manufacturing process

Genzyme Corporation, A Sanofi Company began a recall of LeGoo Endovascular Occlusion Gel-0.5 mL LeGoo w/ no Cannula Product Number: PV-50 LeGoo is a water-soluble, biocompatible polymer with reverse thermo-sensitive... on . FDA classified it as Class II and gives the reason as "Product contains particulates (fibers)". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2142-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Genzyme Corporation, A Sanofi Company
Product
LeGoo Endovascular Occlusion Gel-0.5 mL LeGoo w/ no Cannula Product Number: PV-50 LeGoo is a water-soluble, biocompatible polymer with reverse thermo-sensitive properties allowing it to be injected as a soft viscoelastic gel that forms an elastic plug within the vessel. LeGoo is indicated for temporary endovascular occlusion of blood vessels up to 4 mm in diameter below the neck.
Product code
OBC Occluder, Internal Vessel, Temporary
Reason for recall
Product contains particulates (fibers)
Root cause tag
manufacturing process
FDA root cause
Material/Component Contamination
Action
Genzyme sent a Medical Device Recall Notification letter dated June 21, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were avised to immediately discontinue use of all lots of LeGoo Endovascular Occlusion Gel and return all LeGoo and return product with the shipping label and packing slip enclosed. syringes.Complete the reply card via fax (414) 459-8791. Customer with questions were instructed to call GENCO at 877-674-2087. For questions regarding this recall call 508-270-2285.
Quantity in commerce
5 units
Distribution
Worldwide Distribution - USA (nationwide) and internationally to Austria, Belgium, Canada, Denmark, Egypt. Europe, Finland, France, Germany, Hong Kong, Ireland, Italy, Netherlands, Poland, Saudi Arabia, Slovena, Spain, Sweden, Switzerland, The Netherlands, Turkey, and UK.
Product codes and lots
All lot codes

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2142-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2139-2013Class IITerminatedVoluntary: Firm initiated
Z-2140-2013Class IITerminatedVoluntary: Firm initiated
Z-2141-2013Class IITerminatedVoluntary: Firm initiated
Z-2142-2013Class IITerminatedVoluntary: Firm initiated
Z-2143-2013Class IITerminatedVoluntary: Firm initiated
Z-2144-2013Class IITerminatedVoluntary: Firm initiated
Z-2145-2013Class IITerminatedVoluntary: Firm initiated
Z-2146-2013Class IITerminatedVoluntary: Firm initiated
Z-2147-2013Class IITerminatedVoluntary: Firm initiated
Z-2148-2013Class IITerminatedVoluntary: Firm initiated
Z-2149-2013Class IITerminatedVoluntary: Firm initiated
Z-2150-2013Class IITerminatedVoluntary: Firm initiated
Z-2151-2013Class IITerminatedVoluntary: Firm initiated
Z-2152-2013Class IITerminatedVoluntary: Firm initiated
Z-2153-2013Class IITerminatedVoluntary: Firm initiated
Z-2154-2013Class IITerminatedVoluntary: Firm initiated
Z-2155-2013Class IITerminatedVoluntary: Firm initiated
Z-2156-2013Class IITerminatedVoluntary: Firm initiated